Patent · US Expired

Use of thiadiazolo[4,3-a]pyridine derivatives

US6326378A · kind A · utility

5Cited by

1References

15Claims

0Family size

Assignee

Roche Diagnostics GMBH · DE

Inventors

Walter-Gunar Friebe · Mannheim, DE
Wolfgang Schaumann · Heidelberg, DE
Otto-Henning Wilhelms · Weinheim, DE

Key dates

Filing date	Oct 5, 2000
Grant date	Dec 4, 2001
Priority date	—
Expiry date	Oct 5, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the method of treating leukemia, lymphoma or inhibiting the proliferation of cells with a compound of formula I. ##STR1##

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.